For self-ventilating patients, Aerogen can effectively deliver aerosol medication required for symptom control during respiratory exacerbations.
Product Description
- Significantly fewer treatments and significantly less time required to achieve symptom control
- ~30% relative reduction in hospital admission rates
- 85% of patients achieving symptom control with one 2.5 mg salbutamol dose
- 37-minute reduction in emergency department median length of stay
- 6x more medication delivered to the lungs during self-ventilation versus a jet nebulizer
- Significantly less medication left in the cup versus other nebulizers
Contact our sales team
Interested in the Aerogen Ultra Mask Kits or need our assistance with additional products within the Aerogen range? Complete the form below and our team will be happy to assist.
"*" indicates required fields
